When was Pure Encapsulations founded?

Pure Encapsulations was founded in 2017.

Where is Pure Encapsulations located?

Pure Encapsulations is headquartered in Singapore, Singapore.

Is Pure Encapsulations a funded company?

Pure Encapsulations is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Pure Encapsulations rank among its competitors?

Pure Encapsulations ranks 4063rd amongst 4190 active competitors, of which 115 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Roquette, which secured $4.48M in Jul, 2023.

Who are the top competitors of Pure Encapsulations?

Pure Encapsulations' top competitors include Abbott, WuXi AppTec and Precision Medicine Group. Among them, Roquette secured the most recent funding round in July, 2023.

Pure Encapsulations - 2026 Company Profile & Competitors

Most viewed in 2019

Pure Encapsulations is an unfunded company based in Singapore (Singapore), founded in 2017. It operates as a Manufacturer of nutritional supplements. Pure Encapsulations has not raised any funding yet. The company has 4190 active competitors, including 115 funded and 325 that have exited. Its top competitors include companies like Abbott, WuXi AppTec and Precision Medicine Group.

Key Metrics

Founded Year

2017

Location

Singapore, Singapore

Stage

Unfunded

Ranked

4063^rd among 4190 active competitors

Similar Companies

Abbott & 3508 more

View Pure Encapsulations' full profile

Pure Encapsulations has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pure Encapsulations include Abbott, WuXi AppTec and Precision Medicine Group. Here is the list of Top 10 competitors of Pure Encapsulations, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abbott 1888, Libertyville (United States), Public	Developer of medical devices, generic pharmaceuticals, and nutrition products	-	Digital Pharma Lab, Castle Investment Management ... & 10 others	80/100
2nd	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	79/100
3rd	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Oak Investment Partners & 7 others	71/100
4th	ANI Pharmaceuticals 1996, Baudette (United States), Public	Pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription drugs	-	US Bank, JPMorgan Chase & 4 others	63/100
5th	Aptar 1992, Crystal Lake (United States), Public	Provider of regulatory support, brand differentiation, and prototyping services	-	Al Zayani Investments	63/100
6th	Avania 1988, Brunswick (Australia), Acquired	Provider of regulatory, clinical trials and analytic services	-	Kester Capital, Omnes Capital & 1 others	63/100
7th	Neolife 1958, Fremont (United States), Unfunded	Provider of whole food nutritional supplements	-	-	62/100
8th	Glanbia 1997, Kilkenny (Ireland), Public	Provider of nutritional products and ingredients	-	Europa, Clearway Capital Solutions	59/100
9th	Roquette 1933, Lestrem (France), Funding Raised	CDMO focused on manufacturing of plant based pharma, nutraceuticals, cosmetics, and other products	-	Europa	58/100
10th	Herbalife 1980, Los Angeles (United States), Public	Manufacturer of nutritional supplement products for multiple therapeutic conditions	-	Alua Capital Management, GarMark Partners ... & 1 others	57/100
4063rd	Pure Encapsulations 2017, Singapore (Singapore), Unfunded	Manufacturer of nutritional supplements	-	-	16/100